These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28686543)

  • 1. A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT).
    Brown T; Shao W; Ayub S; Chong D; Cornelius C
    J Psychoactive Drugs; 2017; 49(4):294-296. PubMed ID: 28686543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL; Canton H; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users.
    Cakic V; Potkonyak J; Marshall A
    Drug Alcohol Depend; 2010 Sep; 111(1-2):30-7. PubMed ID: 20570058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
    Riba J; McIlhenny EH; Bouso JC; Barker SA
    Drug Test Anal; 2015 May; 7(5):401-6. PubMed ID: 25069786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.
    Grammenos D; Barker SA
    J Neural Transm (Vienna); 2015 Jun; 122(6):733-9. PubMed ID: 25362533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.
    Murray RM; Oon MC; Rodnight R; Birley JL; Smith A
    Arch Gen Psychiatry; 1979 Jun; 36(6):644-9. PubMed ID: 286576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.
    Jacob MS; Presti DE
    Med Hypotheses; 2005; 64(5):930-7. PubMed ID: 15780487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syrian rue seeds interacted with acacia tree bark in an herbal stew resulted in N,N-dimethyltryptamine poisoning.
    Liu CH; Chu WL; Liao SC; Yang CC; Lin CC
    Clin Toxicol (Phila); 2019 Oct; 57(10):867-869. PubMed ID: 30831037
    [No Abstract]   [Full Text] [Related]  

  • 10. Dimethyltryptamine: Endogenous Role and Therapeutic Potential.
    Rodrigues AV; Almeida FJ; Vieira-Coelho MA
    J Psychoactive Drugs; 2019; 51(4):299-310. PubMed ID: 31018803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).
    Reckweg JT; Uthaug MV; Szabo A; Davis AK; Lancelotta R; Mason NL; Ramaekers JG
    J Neurochem; 2022 Jul; 162(1):128-146. PubMed ID: 35149998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
    Winstock AR; Kaar S; Borschmann R
    J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N,N-Dimethyltryptamine-Induced Psychosis.
    Paterson NE; Darby WC; Sandhu PS
    Clin Neuropharmacol; 2015; 38(4):141-3. PubMed ID: 26166234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients.
    Checkley SA; Murray RM; Oon MC; Rodnight R; Birley JL
    Br J Psychiatry; 1980 Sep; 137():236-9. PubMed ID: 6777009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.
    Jiang XL; Shen HW; Yu AM
    Neuropharmacology; 2015 Feb; 89():342-51. PubMed ID: 25446678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmahuasca: human pharmacology of oral DMT plus harmine.
    Ott J
    J Psychoactive Drugs; 1999; 31(2):171-7. PubMed ID: 10438001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on several 7-substituted N,N-dimethyltryptamines.
    Glennon RA; Schubert E; Jacyno JM; Rosecrans JA
    J Med Chem; 1980 Nov; 23(11):1222-6. PubMed ID: 6779006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)].
    Bickel P; Dittrich A; Schöpf J
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jan; 10(1):10-4. PubMed ID: 329291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases.
    Gomes MM; Coimbra JB; Clara RO; Dörr FA; Moreno AC; Chagas JR; Tufik S; Pinto E; Catalani LH; Campa A
    Biochem Pharmacol; 2014 Apr; 88(3):393-401. PubMed ID: 24508833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.